Sequoia Financial Advisors’s Kazia Therapeutics KZIA Stock Holding History

Sequoia Financial Advisors’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$282K	Sell	20,003 -39,997	-67%	-$487K	﹤0.01%	1718
2026 Q1	$446K	Buy	+60,000	New	+$418K	﹤0.01%	1334

Other funds holding KZIA

FLPIM

F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

UBV

United Bank (Virginia) Vienna, Virginia $853M AUM 34.07% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Sequoia Financial Advisors's KZIA Position: Q2 2026 in Review

Sequoia Financial Advisors reduced its Kazia Therapeutics (KZIA) stake by 67% in Q2 2026, selling an estimated $487K and leaving 20,003 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

Sequoia Financial Advisors first reported a position in KZIA in Q1 2026 and has held it in 2 quarters since. The position peaked at $446K in Q1 2026. 6 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

Sequoia Financial Advisors held 20,003 shares of Kazia Therapeutics worth $282K as of Q2 2026.
Sequoia Financial Advisors sold 39,997 Kazia Therapeutics shares in Q2 2026, an estimated $487K.
Kazia Therapeutics made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1718 holding.
Sequoia Financial Advisors first reported a position in Kazia Therapeutics in Q1 2026 and has held it in 2 quarters since.
Sequoia Financial Advisors's Kazia Therapeutics position peaked at $446K in Q1 2026.
6 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.